Psilocybin firms are excluded from tax Advantages provided to other organizations—large and smaller alike—as a consequence of US tax code 280E. The code prohibits basic deductions for those that interact with Agenda I and Schedule II managed substances. Company facilities are expected to generally compensate for that by possessing price ranges